Will you be part of our future as an investor, or do you have a question about Cassiopea? Please contact us at info@cassiopea.com for general inquiries.
For inquiries regarding press releases and media relations for Cassiopea please contact media@cassiopea.com.
Sign up to stay informed about now FDA-approved WINLEVI® (clascoterone) cream 1%, our first-in-class topical treatment.
Communications about WINLEVI are intended for US healthcare professionals only.
Don’t miss a thing by signing up here for updates.
All fields are required.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc placerat consequat massa. Integer et imperdiet dolor. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nullam in sapien in eros imperdiet iaculis vel quis leo. Nullam risus tortor, ornare ut risus non, bibendum pretium nulla. Sed eu sollicitudin orci. Nam pretium lectus non purus cursus scelerisque. Nunc felis arcu, lacinia dignissim condimentum sed, ultrices a turpis. In nibh urna, auctor vel ornare id, ornare sed orci. Donec ultrices elit quis ipsum sagittis tristique. Etiam finibus tortor id felis varius, eu accumsan nisl rutrum. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed nisl mollis, lacinia lectus nec, porta lectus. In placerat orci diam, ornare sodales enim ornare sed. Pellentesque aliquet, leo quis pulvinar porta, sapien ex cursus leo, ut porta eros justo vitae elit. Morbi consequat ac augue et rhoncus. Phasellus aliquet arcu nisi, sed lacinia mi tristique ac. Quisque ultrices, arcu vitae pulvinar pellentesque, mi orci ultrices felis, a pulvinar diam nulla id mauris. Duis a ante sem. Sed ac ex non tortor ornare viverra nec in magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit. In dictum tellus eget sagittis interdum. In ante sem, pellentesque a ultrices non, ultrices id odio. Curabitur at lacinia elit, ut placerat lectus. Morbi sollicitudin sapien vitae rhoncus dapibus.
